New Results
In vivo KRAS G12D/V Degradation Mediated by CANDDY Using a Modified Proteasome Inhibitor
Satoshi Imanishi, Lijuan Huang, Shoko Itakura, Masamichi Ishizaka, Megumi Tsukamoto, Megumi Saito, Yoichi Iwasaki, Tomohiro Yamaguchi, Etsuko Miyamoto-Sato
doi: https://doi.org/10.1101/2021.04.23.441075
Satoshi Imanishi
1Laboratory of Miyamoto-Sato Molecular Medical Sciences, Research Institute for Science & Technology, Tokyo University of Science, 2641 Yamazaki, Noda, Chiba 278-0022, Japan
Lijuan Huang
1Laboratory of Miyamoto-Sato Molecular Medical Sciences, Research Institute for Science & Technology, Tokyo University of Science, 2641 Yamazaki, Noda, Chiba 278-0022, Japan
Shoko Itakura
2Graduate School of Biological Sciences, Tokyo University of Science, 2641 Yamazaki, Noda, Chiba 278-0022, Japan
Masamichi Ishizaka
1Laboratory of Miyamoto-Sato Molecular Medical Sciences, Research Institute for Science & Technology, Tokyo University of Science, 2641 Yamazaki, Noda, Chiba 278-0022, Japan
Megumi Tsukamoto
1Laboratory of Miyamoto-Sato Molecular Medical Sciences, Research Institute for Science & Technology, Tokyo University of Science, 2641 Yamazaki, Noda, Chiba 278-0022, Japan
Megumi Saito
1Laboratory of Miyamoto-Sato Molecular Medical Sciences, Research Institute for Science & Technology, Tokyo University of Science, 2641 Yamazaki, Noda, Chiba 278-0022, Japan
Yoichi Iwasaki
1Laboratory of Miyamoto-Sato Molecular Medical Sciences, Research Institute for Science & Technology, Tokyo University of Science, 2641 Yamazaki, Noda, Chiba 278-0022, Japan
Tomohiro Yamaguchi
1Laboratory of Miyamoto-Sato Molecular Medical Sciences, Research Institute for Science & Technology, Tokyo University of Science, 2641 Yamazaki, Noda, Chiba 278-0022, Japan
Etsuko Miyamoto-Sato
1Laboratory of Miyamoto-Sato Molecular Medical Sciences, Research Institute for Science & Technology, Tokyo University of Science, 2641 Yamazaki, Noda, Chiba 278-0022, Japan
Posted April 23, 2021.
In vivo KRAS G12D/V Degradation Mediated by CANDDY Using a Modified Proteasome Inhibitor
Satoshi Imanishi, Lijuan Huang, Shoko Itakura, Masamichi Ishizaka, Megumi Tsukamoto, Megumi Saito, Yoichi Iwasaki, Tomohiro Yamaguchi, Etsuko Miyamoto-Sato
bioRxiv 2021.04.23.441075; doi: https://doi.org/10.1101/2021.04.23.441075
In vivo KRAS G12D/V Degradation Mediated by CANDDY Using a Modified Proteasome Inhibitor
Satoshi Imanishi, Lijuan Huang, Shoko Itakura, Masamichi Ishizaka, Megumi Tsukamoto, Megumi Saito, Yoichi Iwasaki, Tomohiro Yamaguchi, Etsuko Miyamoto-Sato
bioRxiv 2021.04.23.441075; doi: https://doi.org/10.1101/2021.04.23.441075
Subject Area
Subject Areas
- Biochemistry (13371)
- Bioengineering (10182)
- Bioinformatics (32560)
- Biophysics (16756)
- Cancer Biology (13849)
- Cell Biology (19670)
- Clinical Trials (138)
- Developmental Biology (10626)
- Ecology (15729)
- Epidemiology (2067)
- Evolutionary Biology (20037)
- Genetics (13231)
- Genomics (18362)
- Immunology (13470)
- Microbiology (31528)
- Molecular Biology (13148)
- Neuroscience (68675)
- Paleontology (509)
- Pathology (2129)
- Pharmacology and Toxicology (3675)
- Physiology (5735)
- Plant Biology (11784)
- Synthetic Biology (3307)
- Systems Biology (8038)
- Zoology (1814)